Economic considerations for pharmacogenetic testing

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

StandardStandard

Economic considerations for pharmacogenetic testing. / Hughes, D.; Hughes, D.A.
2008. Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK.

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

HarvardHarvard

Hughes, D & Hughes, DA 2008, 'Economic considerations for pharmacogenetic testing', Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK, 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2008). Economic considerations for pharmacogenetic testing. Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK.

CBE

Hughes D, Hughes DA. 2008. Economic considerations for pharmacogenetic testing. Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK.

MLA

Hughes, D. a D.A. Hughes Economic considerations for pharmacogenetic testing. Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK, 03 Ion 0001, Papur, 2008.

VancouverVancouver

Hughes D, Hughes DA. Economic considerations for pharmacogenetic testing. 2008. Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK.

Author

Hughes, D. ; Hughes, D.A. / Economic considerations for pharmacogenetic testing. Papur a gyflwynwyd yn Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK.

RIS

TY - CONF

T1 - Economic considerations for pharmacogenetic testing

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2008/6/1

Y1 - 2008/6/1

M3 - Paper

T2 - Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK

Y2 - 3 January 0001

ER -